Emily Ha
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
Papers in
-
- Advanced biosensing and bioanalysis techniques 3
- RNA Interference and Gene Delivery 2
- Protein purification and stability 1
- Viral Infectious Diseases and Gene Expression in Insects 1
-
- MXene and MAX Phase Materials 2
- Co-authors
- Wei Wang (1 shared paper)Xi Zhu (2 shared papers)Qing Li (2 shared papers)Xiaoding Xu (2 shared papers)Mikyung Yu (2 shared papers)Jinjun Shi (2 shared papers)Omid C. Farokhzad (2 shared papers)Yanlan Liu (2 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (1 paper)Canadian Family Physician (1 paper)RSC Advances (1 paper)Angewandte Chemie International Edition (1 paper)JMIR Human Factors (1 paper)
- Partner nations
- United StatesCanadaSaudi Arabia
In The Last Decade
Emily Ha
5 papers receiving 472 citations
Peers
Comparison fields: 5 of 65
- Biomaterials 130
- Pharmaceutical Science 36
- Molecular Biology 321
- Biomedical Engineering 147
- Occupational Therapy 13
Countries citing papers authored by Emily Ha
This map shows the geographic impact of Emily Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Ha more than expected).
Fields of papers citing papers by Emily Ha
This network shows the impact of papers produced by Emily Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Ha. The network helps show where Emily Ha may publish in the future.
Co-authors
The 18 scholars most cited alongside Emily Ha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 225 | |
| 2 | 2002 | 219 | |
| 3 | 2017 | 18 | |
| 4 | 2016 | 13 | |
| 5 | 2025 | 8 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 |
About Emily Ha
Emily Ha is a scholar working on Molecular Biology, Materials Chemistry, Health Informatics, General Health Professions and Biomaterials, having authored 7 papers that have together received 483 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (3 papers), Artificial Intelligence in Healthcare and Education (2 papers), MXene and MAX Phase Materials (2 papers), RNA Interference and Gene Delivery (2 papers), Protein purification and stability (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Healthcare Policy and Management (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Biomaterials (130 citations), Pharmaceutical Science (36 citations), Molecular Biology (321 citations), Biomedical Engineering (147 citations) and Occupational Therapy (13 citations). Emily Ha has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Wei Wang, Xi Zhu, Qing Li, Xiaoding Xu, Mikyung Yu, Jinjun Shi, Omid C. Farokhzad, Yanlan Liu, Jun Wu and Lili Zhao. Their work appears in journals such as Journal of Pharmaceutical Sciences, Canadian Family Physician, RSC Advances, Angewandte Chemie International Edition and JMIR Human Factors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.